Hikma expands Ohio site it got in Roxane deal, adding 95 workers

Hikma is expanding the large manufacturing site in Columbus, OH, it acquired in 2015 from Boehringer Ingelheim.

Jordan-based Hikma is expanding the manufacturing and distribution operations at a large solid-dose manufacturing site it picked up in 2015 from Boehringer Ingelheim, adding about 100 jobs in the process. 

HIkma’s West-Ward generics division has committed to adding 65 jobs as part of an expansion of the solid dose plant in Columbus, OH, in exchange for a 7-year tax credit worth up to $100,000 that was granted this week by the Ohio Tax Credit Authority, Columbus Business First reports.

Hikma got the 875,000-square-foot manufacturing site in Columbus with its $2.65 billion buyout in 2015 of Roxanne Laboratories, the U.S. generics business of Germany’s Boehringer Ingelheim. Hikma folded the new operation into its U.S.-based West-Ward, which produces both sterile injectables and solid dose products.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

Work on a 30,300-square-foot, two-story expansion to the west Columbus plant began last summer, Business First says, and  is expected to open in phases through May 2018.

In addition, West-Ward is building a 276,000-square-foot distribution facility in nearby Obetz where it will add another 30 jobs.

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.